Biotech Analyst Agrawal, along with Dr. Saidha, Neurology Professor at John Hopkins University, discuss TG Therapeutics’ Briumvi launch in Multiple Sclerosis on an Analyst/Industry conference call to be held on May 3 at 12 pm. Webcast Link
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on TGTX:
- TG Therapeutics to Participate in the Bank of America Securities 2023 Health Care Conference
- Cantor Fitzgerald biotech analyst to hold analyst/industry conference call
- TG Therapeutics price target raised to $34 from $28 at JPMorgan
- TG Therapeutics price target raised to $37.50 from $26 at Ladenburg
- TG Therapeutics price target raised to $34 from $28 at H.C. Wainwright
